Particulars Number Cytogenetic Response (Peripheral Blood)  Complete   Partial      No response   Gender Male 16 05 09 02 Female 14 04 07 03 Age >45 11 04 06 01 <45 19 05 10 04 Dwelling Urban 12 03 06 03 Rural 18 06 10 02 TLC+Spleen (Baseline) Raised 30 ------ ------ ------ Normal 00 ------ ------ ------ BCR-ABL q-PCR value (Baseline) >80% 30 ------ ------ ------ <80% 00 ------ ------ ------  Karyotyping (Baseline) Ph+ve(>80%) 30 ------ ------ ------ Ph-ve 00 ------ ------ ------ TLC+Spleen (Follow up) Raised 05 00 00 05 Normal 25 09 16 00 BCR-ABL q-PCR value (Follow-up) 0-40 % 09 ------ ------ 40-60% ------ 16 ------ 60-80% ------ ------ 05 Karyotyping (Follow up) Ph+ve 05 00 00 05 Ph-ve 25 09 16 00

Table 1: Patients particulars and ‘Peripheral blood cytogenetic response’ at 3 months of ‘Imatinib’ treatment.